Cross-border M&A between U.S. and European firms at 10 year high
Reuters
Published May 22, 2017 09:21AM ET
Cross-border M&A between U.S. and European firms at 10 year high
By Pamela Barbaglia
LONDON (Reuters) - Some $171.8 billion of cross-border merger and acquisition deals between U.S. and European companies have been announced so far in 2017, the highest figure at this stage of the year for a decade as companies on both sides of the Atlantic hunt for deals to offset sluggish growth.
A $14 billion tie-up between U.S.-based chemicals firm Huntsman Corp (N:HUN) and European rival Swiss Clariant AG (S:CLN), announced on Monday, is the latest example of the spate of big deals between the two regions.
The overall value of cross-border M&A deals between the U.S. and Europe is up 82 percent on the same period last year, according to Thomson Reuters data, and the highest over the same timeframe since at least 2007.
Interest in major cross-border deals was underscored earlier this year when Kraft Heinz Co (O:KHC) made a surprise $143 billion bid for Unilever (L:ULVR) (AS:UNc), only to withdraw it less than 48 hours later, while U.S. healthcare giant Johnson & Johnson (N:JNJ) clinched Swiss biotech company Actelion (S:ATLN) in a $30 billion all-cash deal.
Optimism over U.S. President Donald Trump's economic agenda has buoyed stock markets worldwide, as well as the U.S. dollar, which has made foreign acquisitions cheaper for U.S. companies.
Low interest rates are also keeping down borrowing costs.
Switzerland and the Netherlands have so far been the main shopping destinations for companies on the other side of the Atlantic, with U.S. buyers announcing a combined $70.2 billion worth of deals in those two countries this year, the data shows.
But some European companies have been fighting hard for their independence.
Shareholders in Dutch paint maker Akzo Nobel (AS:AKZO), angered by its rejection of a 26.3 billion euro ($29.6 billion)takeover proposal from U.S. rival PPG Industries (N:PPG), took their fight to an Amsterdam court on Monday.
Britain remains Europe's biggest acquirer in the United States, with deals totaling $21.1 billion so far this year, followed by Switzerland with $11.5 billion.
In February, Reckitt Benckiser (L:RB) announced a deal to buy U.S. baby formula maker Mead Johnson Nutrition (N:MJN) for $16.6 billion, giving the British consumer goods company a new product line and expanding its presence in developing markets where Mead Johnson has a strong footprint.
Get The News You Want
Bank of America Merrill Lynch, which advised Reckitt Benckiser on that deal, leads the list of financial advisers on cross-border transactions announced between U.S. and European companies, with $83.1 billion worth of deals so far this year.
That represents 48 percent of the total, according to Thomson Reuters data.
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.